Indegene buys BioPharm for $106 mn to boost AI-driven pharma marketing
Healthcare tech firm Indegene has announced the acquisition of BioPharm, a Pennsylvania-based specialised marketing services agency and part of Omnicom Health Group, for $106 million. BioPharm delivers marketing and communications solutions to life sciences clients across North America.
